mnBL11q feature DLBCL signatures such as elevated expression of spots E (PIM1), F (inflammation) and K (B-cell activation, BCL6), reflecting intermediate characteristics between BL and DLBCL. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.